70 A Randomized, Double-Blind, Placebo-Controlled Phase II Study (MOT114479) to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Orally Administered Camicinal, a Motilin Receptor Agonist, in Diabetics With GastroparesisMatthew E. Barton, George E. Dukes, Lakshmi Vasist Johnson et al.|Gastroenterology|2014Cited by 34